(893394, 'HP:0031599', 'P mitrale', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893395, 'HP:0031599', 'P mitrale', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893396, 'HP:0031599', 'P mitrale', 'MP:0002952', 'ventricular cardiomyopathy', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893397, 'HP:0031599', 'P mitrale', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893398, 'HP:0031599', 'P mitrale', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893399, 'HP:0031599', 'P mitrale', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893400, 'HP:0031599', 'P mitrale', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893401, 'HP:0031599', 'P mitrale', 'MP:0003037', 'increased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893402, 'HP:0031599', 'P mitrale', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893403, 'HP:0031599', 'P mitrale', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893404, 'HP:0031599', 'P mitrale', 'MP:0010392', 'prolonged QRS complex duration', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893405, 'HP:0031599', 'P mitrale', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893406, 'HP:0031599', 'P mitrale', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893407, 'HP:0031599', 'P mitrale', 'MP:0000343', 'abnormal response to cardiac infarction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893408, 'HP:0031599', 'P mitrale', 'MP:0005140', 'decreased cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893409, 'HP:0031599', 'P mitrale', 'MP:0009384', 'cardiac valve regurgitation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893410, 'HP:0031599', 'P mitrale', 'MP:0004217', 'salt-sensitive hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893411, 'HP:0031599', 'P mitrale', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893412, 'HP:0031599', 'P mitrale', 'MP:0010506', 'prolonged RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893413, 'HP:0031599', 'P mitrale', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893414, 'HP:0031599', 'P mitrale', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893415, 'HP:0031599', 'P mitrale', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893416, 'HP:0031599', 'P mitrale', 'MP:0010637', 'sinus bradycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893417, 'HP:0031599', 'P mitrale', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893418, 'HP:0031599', 'P mitrale', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893419, 'HP:0031599', 'P mitrale', 'MP:0031136', 'muscle hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893420, 'HP:0031599', 'P mitrale', 'MP:0011514', 'skin hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893421, 'HP:0031599', 'P mitrale', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893422, 'HP:0031599', 'P mitrale', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893423, 'HP:0031599', 'P mitrale', 'MP:0004070', 'abnormal P wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893424, 'HP:0031599', 'P mitrale', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893425, 'HP:0031599', 'P mitrale', 'MP:0010553', 'prolonged HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893426, 'HP:0031599', 'P mitrale', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893427, 'HP:0031599', 'P mitrale', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893428, 'HP:0031599', 'P mitrale', 'MP:0003897', 'abnormal ST segment', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893429, 'HP:0031599', 'P mitrale', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893430, 'HP:0031599', 'P mitrale', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893431, 'HP:0031599', 'P mitrale', 'MP:0005333', 'decreased heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893432, 'HP:0031599', 'P mitrale', 'MP:0004156', 'abnormal QT variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893433, 'HP:0031599', 'P mitrale', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893434, 'HP:0031599', 'P mitrale', 'MP:0008950', 'ventricular tachycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893435, 'HP:0031599', 'P mitrale', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893436, 'HP:0031599', 'P mitrale', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893437, 'HP:0031599', 'P mitrale', 'MP:0002626', 'increased heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893438, 'HP:0031599', 'P mitrale', 'MP:0009275', 'bruising', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893439, 'HP:0031599', 'P mitrale', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893440, 'HP:0031599', 'P mitrale', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893441, 'HP:0031599', 'P mitrale', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893442, 'HP:0031599', 'P mitrale', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893443, 'HP:0031599', 'P mitrale', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893444, 'HP:0031599', 'P mitrale', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893445, 'HP:0031599', 'P mitrale', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893446, 'HP:0031599', 'P mitrale', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893447, 'HP:0031599', 'P mitrale', 'MP:0012045', 'increased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893448, 'HP:0031599', 'P mitrale', 'MP:0003896', 'prolonged PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893449, 'HP:0031599', 'P mitrale', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893450, 'HP:0031599', 'P mitrale', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893451, 'HP:0031599', 'P mitrale', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893452, 'HP:0031599', 'P mitrale', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893453, 'HP:0031599', 'P mitrale', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893454, 'HP:0031599', 'P mitrale', 'MP:0005600', 'increased ventricle muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893455, 'HP:0031599', 'P mitrale', 'MP:0001636', 'irregular heartbeat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893456, 'HP:0031599', 'P mitrale', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893457, 'HP:0031599', 'P mitrale', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893458, 'HP:0031599', 'P mitrale', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893459, 'HP:0031599', 'P mitrale', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893460, 'HP:0031599', 'P mitrale', 'MP:0011953', 'prolonged PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893461, 'HP:0031599', 'P mitrale', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893462, 'HP:0031599', 'P mitrale', 'MP:0003394', 'increased cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893463, 'HP:0031599', 'P mitrale', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893464, 'HP:0031599', 'P mitrale', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893465, 'HP:0031599', 'P mitrale', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893466, 'HP:0031599', 'P mitrale', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893467, 'HP:0031599', 'P mitrale', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893468, 'HP:0031599', 'P mitrale', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893469, 'HP:0031599', 'P mitrale', 'MP:0006265', 'increased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893470, 'HP:0031599', 'P mitrale', 'MP:0000465', 'gastrointestinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893471, 'HP:0031599', 'P mitrale', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893472, 'HP:0031599', 'P mitrale', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893473, 'HP:0031599', 'P mitrale', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893474, 'HP:0031599', 'P mitrale', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893475, 'HP:0031599', 'P mitrale', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893476, 'HP:0031599', 'P mitrale', 'MP:0011951', 'increased cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893477, 'HP:0031599', 'P mitrale', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893478, 'HP:0031599', 'P mitrale', 'MP:0004071', 'prolonged P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893479, 'HP:0031599', 'P mitrale', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893480, 'HP:0031599', 'P mitrale', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893481, 'HP:0031599', 'P mitrale', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893482, 'HP:0031599', 'P mitrale', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893483, 'HP:0031599', 'P mitrale', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893484, 'HP:0031599', 'P mitrale', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893485, 'HP:0031599', 'P mitrale', 'MP:0003820', 'increased left ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893486, 'HP:0031599', 'P mitrale', 'MP:0009698', 'heart hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893487, 'HP:0031599', 'P mitrale', 'MP:0005532', 'abnormal vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893488, 'HP:0031599', 'P mitrale', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893489, 'HP:0031599', 'P mitrale', 'MP:0003882', 'abnormal pulse pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893490, 'HP:0031599', 'P mitrale', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893491, 'HP:0031599', 'P mitrale', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893492, 'HP:0031599', 'P mitrale', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893493, 'HP:0031599', 'P mitrale', 'MP:0004216', 'salt-resistant hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893494, 'HP:0031599', 'P mitrale', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893495, 'HP:0031599', 'P mitrale', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893496, 'HP:0031599', 'P mitrale', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893497, 'HP:0031599', 'P mitrale', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893498, 'HP:0031599', 'P mitrale', 'MP:0011920', 'abnormal S wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893499, 'HP:0031599', 'P mitrale', 'MP:0004010', 'increased diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893500, 'HP:0031599', 'P mitrale', 'MP:0010758', 'increased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893501, 'HP:0031599', 'P mitrale', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893502, 'HP:0031599', 'P mitrale', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893503, 'HP:0031599', 'P mitrale', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893504, 'HP:0031599', 'P mitrale', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893505, 'HP:0031599', 'P mitrale', 'MP:0004485', 'increased response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893506, 'HP:0031599', 'P mitrale', 'MP:0010511', 'shortened PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893507, 'HP:0031599', 'P mitrale', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893508, 'HP:0031599', 'P mitrale', 'MP:0010554', 'shortened HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893509, 'HP:0031599', 'P mitrale', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893510, 'HP:0031599', 'P mitrale', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893511, 'HP:0031599', 'P mitrale', 'MP:0031170', 'abnormal vasculature physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893512, 'HP:0031599', 'P mitrale', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893513, 'HP:0031599', 'P mitrale', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893514, 'HP:0031599', 'P mitrale', 'MP:0031154', 'intestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893515, 'HP:0031599', 'P mitrale', 'MP:0004879', 'decreased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893516, 'HP:0031599', 'P mitrale', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893517, 'HP:0031599', 'P mitrale', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893518, 'HP:0031599', 'P mitrale', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893519, 'HP:0031599', 'P mitrale', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893520, 'HP:0031599', 'P mitrale', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893521, 'HP:0031599', 'P mitrale', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893522, 'HP:0031599', 'P mitrale', 'MP:0031129', 'left-to-right shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893523, 'HP:0031599', 'P mitrale', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893524, 'HP:0031599', 'P mitrale', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893525, 'HP:0031599', 'P mitrale', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893526, 'HP:0031599', 'P mitrale', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893527, 'HP:0031599', 'P mitrale', 'MP:0003034', 'increased pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893528, 'HP:0031599', 'P mitrale', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893529, 'HP:0031599', 'P mitrale', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893530, 'HP:0031599', 'P mitrale', 'MP:0001629', 'abnormal heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893531, 'HP:0031599', 'P mitrale', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893532, 'HP:0031599', 'P mitrale', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893533, 'HP:0031599', 'P mitrale', 'MP:0010515', 'abnormal Q wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893534, 'HP:0031599', 'P mitrale', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893535, 'HP:0031599', 'P mitrale', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893536, 'HP:0031599', 'P mitrale', 'MP:0006266', 'decreased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893537, 'HP:0031599', 'P mitrale', 'MP:0010393', 'shortened QRS complex duration', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893538, 'HP:0031599', 'P mitrale', 'MP:0004877', 'abnormal systemic vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893539, 'HP:0031599', 'P mitrale', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893540, 'HP:0031599', 'P mitrale', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893541, 'HP:0031599', 'P mitrale', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893542, 'HP:0031599', 'P mitrale', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893543, 'HP:0031599', 'P mitrale', 'MP:0006045', 'mitral valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893544, 'HP:0031599', 'P mitrale', 'MP:0004878', 'increased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893545, 'HP:0031599', 'P mitrale', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893546, 'HP:0031599', 'P mitrale', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893547, 'HP:0031599', 'P mitrale', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893548, 'HP:0031599', 'P mitrale', 'MP:0003549', 'pulmonary hypotension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893549, 'HP:0031599', 'P mitrale', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893550, 'HP:0031599', 'P mitrale', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893551, 'HP:0031599', 'P mitrale', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893552, 'HP:0031599', 'P mitrale', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893553, 'HP:0031599', 'P mitrale', 'MP:0011926', 'abnormal heart valve physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893554, 'HP:0031599', 'P mitrale', 'MP:0010513', 'abnormal ventricular activation time', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893555, 'HP:0031599', 'P mitrale', 'MP:0010514', 'fragmented QRS complex', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893556, 'HP:0031599', 'P mitrale', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893557, 'HP:0031599', 'P mitrale', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893558, 'HP:0031599', 'P mitrale', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893559, 'HP:0031599', 'P mitrale', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893560, 'HP:0031599', 'P mitrale', 'MP:0013135', 'poor circulation in tail', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893561, 'HP:0031599', 'P mitrale', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893562, 'HP:0031599', 'P mitrale', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893563, 'HP:0031599', 'P mitrale', 'MP:0001633', 'poor circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893564, 'HP:0031599', 'P mitrale', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893565, 'HP:0031599', 'P mitrale', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893566, 'HP:0031599', 'P mitrale', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893567, 'HP:0031599', 'P mitrale', 'MP:0020097', 'low mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893568, 'HP:0031599', 'P mitrale', 'MP:0003901', 'abnormal PR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893569, 'HP:0031599', 'P mitrale', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893570, 'HP:0031599', 'P mitrale', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893571, 'HP:0031599', 'P mitrale', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893572, 'HP:0031599', 'P mitrale', 'MP:0011936', 'abnormal PP interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893573, 'HP:0031599', 'P mitrale', 'MP:0031152', 'subcutaneous hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893574, 'HP:0031599', 'P mitrale', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893575, 'HP:0031599', 'P mitrale', 'MP:0031130', 'right-to-left shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(893576, 'HP:0031599', 'P mitrale', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893577, 'HP:0031599', 'P mitrale', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893578, 'HP:0031599', 'P mitrale', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893579, 'HP:0031731', 'Increased tear production', 'MP:0005551', 'abnormal eye electrophysiology', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893580, 'HP:0031731', 'Increased tear production', 'MP:0012145', 'increased a-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893581, 'HP:0031731', 'Increased tear production', 'MP:0006194', 'keratoconjunctivitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893582, 'HP:0031731', 'Increased tear production', 'MP:0012153', 'increased b-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893583, 'HP:0031731', 'Increased tear production', 'MP:0020962', 'increased c-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893584, 'HP:0031731', 'Increased tear production', 'MP:0020861', 'abnormal corneal wound healing', 0.47368421052631576, 8.795504987450572, 2.041149635906392, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893585, 'HP:0031731', 'Increased tear production', 'MP:0001313', 'increased incidence of corneal inflammation', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893586, 'HP:0031731', 'Increased tear production', 'MP:0020963', 'decreased c-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893587, 'HP:0031731', 'Increased tear production', 'MP:0020961', 'abnormal c-wave amplitude', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893588, 'HP:0031731', 'Increased tear production', 'MP:0014132', 'abnormal tear film physiology', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893589, 'HP:0031731', 'Increased tear production', 'MP:0006201', 'vitreous body inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893590, 'HP:0031731', 'Increased tear production', 'MP:0012146', 'increased b-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893591, 'HP:0031731', 'Increased tear production', 'MP:0010748', 'abnormal visual evoked potential', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893592, 'HP:0031731', 'Increased tear production', 'MP:0030006', 'decreased retina apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893593, 'HP:0031731', 'Increased tear production', 'MP:0020979', 'decreased FO-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893594, 'HP:0031731', 'Increased tear production', 'MP:0006190', 'retina ischemia', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893595, 'HP:0031731', 'Increased tear production', 'MP:0001851', 'eye inflammation', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893596, 'HP:0031731', 'Increased tear production', 'MP:0012144', 'decreased b-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893597, 'HP:0031731', 'Increased tear production', 'MP:0006072', 'abnormal retina apoptosis', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893598, 'HP:0031731', 'Increased tear production', 'MP:0006157', 'palsy of the eye', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893599, 'HP:0031731', 'Increased tear production', 'MP:0020220', 'decreased tear production', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893600, 'HP:0031731', 'Increased tear production', 'MP:0020860', 'abnormal cornea physiology', 0.5294117647058824, 8.795504987450572, 2.1578794722795798, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893601, 'HP:0031731', 'Increased tear production', 'MP:0013468', 'chromodacryorrhea', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893602, 'HP:0031731', 'Increased tear production', 'MP:0020219', 'increased tear production', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893603, 'HP:0031731', 'Increased tear production', 'MP:0001848', 'choroid inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893604, 'HP:0031731', 'Increased tear production', 'MP:0006229', 'iris inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893605, 'HP:0031731', 'Increased tear production', 'MP:0006145', 'legal blindness', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893606, 'HP:0031731', 'Increased tear production', 'MP:0006251', 'eyelid apraxia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893607, 'HP:0031731', 'Increased tear production', 'MP:0012148', 'decreased a-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893608, 'HP:0031731', 'Increased tear production', 'MP:0006152', 'tunnel vision', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893609, 'HP:0031731', 'Increased tear production', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893610, 'HP:0031731', 'Increased tear production', 'MP:0020977', 'decreased FO-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893611, 'HP:0031731', 'Increased tear production', 'MP:0008145', 'hemeralopia', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893612, 'HP:0031731', 'Increased tear production', 'MP:0013787', 'photophobia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893613, 'HP:0031731', 'Increased tear production', 'MP:0012040', 'abnormal c-wave shape', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893614, 'HP:0031731', 'Increased tear production', 'MP:0014157', 'alacrima', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893615, 'HP:0031731', 'Increased tear production', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893616, 'HP:0031731', 'Increased tear production', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893617, 'HP:0031731', 'Increased tear production', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893618, 'HP:0031731', 'Increased tear production', 'MP:0012030', 'abnormal a-wave amplitude', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893619, 'HP:0031731', 'Increased tear production', 'MP:0020980', 'increased FO-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893620, 'HP:0031731', 'Increased tear production', 'MP:0012037', 'abnormal b-wave latency', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893621, 'HP:0031731', 'Increased tear production', 'MP:0005253', 'abnormal eye physiology', 0.53125, 8.795504987450572, 2.161622544428864, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893622, 'HP:0031731', 'Increased tear production', 'MP:0003096', 'increased corneal light-scattering', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893623, 'HP:0031731', 'Increased tear production', 'MP:0005251', 'blepharitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893624, 'HP:0031731', 'Increased tear production', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893625, 'HP:0031731', 'Increased tear production', 'MP:0020976', 'increased FO-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893626, 'HP:0031731', 'Increased tear production', 'MP:0006147', 'monocular blindness', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893627, 'HP:0031731', 'Increased tear production', 'MP:0013145', 'eye discharge', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893628, 'HP:0031731', 'Increased tear production', 'MP:0011275', 'abnormal behavioral response to light', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893629, 'HP:0031731', 'Increased tear production', 'MP:0012143', 'decreased a-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893630, 'HP:0031731', 'Increased tear production', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893631, 'HP:0031731', 'Increased tear production', 'MP:0012152', 'decreased a-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893632, 'HP:0031731', 'Increased tear production', 'MP:0012149', 'decreased b-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893633, 'HP:0031731', 'Increased tear production', 'MP:0012032', 'abnormal ERG latency', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893634, 'HP:0031731', 'Increased tear production', 'MP:0005257', 'abnormal intraocular pressure', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893635, 'HP:0031731', 'Increased tear production', 'MP:0020439', 'absent b-wave', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893636, 'HP:0031731', 'Increased tear production', 'MP:0003011', 'delayed dark adaptation', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893637, 'HP:0031731', 'Increased tear production', 'MP:0001999', 'photosensitivity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893638, 'HP:0031731', 'Increased tear production', 'MP:0012035', 'abnormal b-wave shape', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893639, 'HP:0031731', 'Increased tear production', 'MP:0012147', 'increased a-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893640, 'HP:0031731', 'Increased tear production', 'MP:0008144', 'nyctalopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893641, 'HP:0031731', 'Increased tear production', 'MP:0013478', 'corneal limbitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893642, 'HP:0031731', 'Increased tear production', 'MP:0020218', 'abnormal tear production', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893643, 'HP:0031731', 'Increased tear production', 'MP:0020960', 'increased c-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893644, 'HP:0031731', 'Increased tear production', 'MP:0012036', 'abnormal a-wave latency', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893645, 'HP:0031731', 'Increased tear production', 'MP:0006252', 'lateral rectus palsy', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893646, 'HP:0031731', 'Increased tear production', 'MP:0020974', 'abnormal FO-wave shape', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893647, 'HP:0031731', 'Increased tear production', 'MP:0001348', 'abnormal lacrimal gland physiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893648, 'HP:0031731', 'Increased tear production', 'MP:0006150', 'double vision', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893649, 'HP:0031731', 'Increased tear production', 'MP:0031497', 'increased visual acuity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893650, 'HP:0031731', 'Increased tear production', 'MP:0004021', 'abnormal rod electrophysiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893651, 'HP:0031731', 'Increased tear production', 'MP:0006149', 'decreased visual acuity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893652, 'HP:0031731', 'Increased tear production', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893653, 'HP:0031731', 'Increased tear production', 'MP:0008796', 'increased lens fiber apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893654, 'HP:0031731', 'Increased tear production', 'MP:0005515', 'uveitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893655, 'HP:0031731', 'Increased tear production', 'MP:0003101', 'high myopia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893656, 'HP:0031731', 'Increased tear production', 'MP:0011832', 'abnormal visual acuity', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893657, 'HP:0031731', 'Increased tear production', 'MP:0006224', 'oculomotor apraxia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893658, 'HP:0031731', 'Increased tear production', 'MP:0005258', 'ocular hypertension', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893659, 'HP:0031731', 'Increased tear production', 'MP:0004022', 'abnormal cone electrophysiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893660, 'HP:0031731', 'Increased tear production', 'MP:0001337', 'dry eyes', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893661, 'HP:0031731', 'Increased tear production', 'MP:0003100', 'myopia', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893662, 'HP:0031731', 'Increased tear production', 'MP:0002638', 'abnormal pupillary reflex', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893663, 'HP:0031731', 'Increased tear production', 'MP:0030933', 'hyphema', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893664, 'HP:0031731', 'Increased tear production', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893665, 'HP:0031731', 'Increased tear production', 'MP:0020958', 'abnormal c-wave implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893666, 'HP:0031731', 'Increased tear production', 'MP:0013479', 'scleritis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893667, 'HP:0031731', 'Increased tear production', 'MP:0006203', 'eye hemorrhage', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893668, 'HP:0031731', 'Increased tear production', 'MP:0010749', 'absent visual evoked potential', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893669, 'HP:0031731', 'Increased tear production', 'MP:0012034', 'abnormal a-wave shape', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893670, 'HP:0031731', 'Increased tear production', 'MP:0012154', 'decreased b-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893671, 'HP:0031731', 'Increased tear production', 'MP:0006153', 'hypermetropia', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893672, 'HP:0031731', 'Increased tear production', 'MP:0012150', 'increased b-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893673, 'HP:0031731', 'Increased tear production', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893674, 'HP:0031731', 'Increased tear production', 'MP:0006156', 'abnormal visual pursuit', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893675, 'HP:0031731', 'Increased tear production', 'MP:0001389', 'abnormal eye movement', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893676, 'HP:0031731', 'Increased tear production', 'MP:0005260', 'ocular hypotension', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893677, 'HP:0031731', 'Increased tear production', 'MP:0030144', 'abnormal facial muscle physiology', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(893678, 'HP:0031731', 'Increased tear production', 'MP:0012038', 'abnormal a-wave implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893679, 'HP:0031731', 'Increased tear production', 'MP:0003665', 'endophthalmitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893680, 'HP:0031731', 'Increased tear production', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893681, 'HP:0031731', 'Increased tear production', 'MP:0002001', 'blindness', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893682, 'HP:0031731', 'Increased tear production', 'MP:0006148', 'binocular blindness', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893683, 'HP:0031731', 'Increased tear production', 'MP:0012151', 'increased a-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893684, 'HP:0031731', 'Increased tear production', 'MP:0001852', 'conjunctivitis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893685, 'HP:0031731', 'Increased tear production', 'MP:0012031', 'abnormal b-wave amplitude', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893686, 'HP:0031731', 'Increased tear production', 'MP:0008794', 'increased lens epithelium apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893687, 'HP:0031731', 'Increased tear production', 'MP:0003878', 'abnormal ear physiology', 0.4117647058823529, 5.059610039003922, 1.4433879726497136, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893688, 'HP:0031731', 'Increased tear production', 'MP:0012039', 'abnormal b-wave implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893689, 'HP:0031731', 'Increased tear production', 'MP:0002090', 'abnormal vision', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893690, 'HP:0031731', 'Increased tear production', 'MP:0013466', 'keratoconjunctivitis sicca', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893691, 'HP:0031731', 'Increased tear production', 'MP:0013480', 'cyclitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893692, 'HP:0031731', 'Increased tear production', 'MP:0012033', 'abnormal ERG implicit time', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893693, 'HP:0031731', 'Increased tear production', 'MP:0020959', 'decreased c-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893694, 'HP:0031731', 'Increased tear production', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893695, 'HP:0031731', 'Increased tear production', 'MP:0030005', 'increased retina apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893696, 'HP:0031731', 'Increased tear production', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(893697, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0014161', 'increased circulating cortisol level', 0.40425531914893614, 10.169741955603977, 2.027602594179888, 'UPHENO:0076293', 'abnormal hormone blood level'),
(893698, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0014162', 'decreased circulating cortisol level', 0.40425531914893614, 10.169741955603977, 2.027602594179888, 'UPHENO:0076293', 'abnormal hormone blood level'),
(893699, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893700, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0013277', 'abnormal fasting circulating glucose level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(893701, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0011888', 'abnormal circulating total protein level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893702, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0005180', 'abnormal circulating testosterone level', 0.42857142857142855, 12.982656403003482, 2.35881232854316, 'UPHENO:0076290', 'abnormal androgen blood level'),
(893703, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893704, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0003366', 'abnormal circulating glucocorticoid level', 0.4222222222222222, 10.169741955603977, 2.0721706126479256, 'UPHENO:0076293', 'abnormal hormone blood level'),
(893705, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(893706, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0005416', 'abnormal circulating protein level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(893707, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0013403', 'abnormal circulating lactate level', 0.4358974358974359, 7.550058075704454, 1.8141253970098927, 'UPHENO:0076286', 'abnormal role blood level'),
(893708, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0003372', 'abnormal circulating mineralocorticoid level', 0.4222222222222222, 10.169741955603977, 2.0721706126479256, 'UPHENO:0076293', 'abnormal hormone blood level'),
(893709, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0011912', 'abnormal circulating fibronectin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893710, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893711, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0002329', 'abnormal blood gas level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(893712, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0011889', 'abnormal circulating ferritin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893713, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4523809523809524, 10.169741955603977, 2.1449003593045193, 'UPHENO:0076293', 'abnormal hormone blood level'),
(893714, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893715, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0003018', 'abnormal circulating chloride level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893716, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0000188', 'abnormal circulating glucose level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(893717, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0014160', 'abnormal circulating cortisol level', 0.41304347826086957, 10.169741955603977, 2.0495232592869406, 'UPHENO:0076293', 'abnormal hormone blood level'),
(893718, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0008820', 'abnormal blood uric acid level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(893719, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0012221', 'abnormal circulating prothrombin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893720, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0011892', 'abnormal circulating transferrin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893721, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0012549', 'hypoxemia', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893722, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0031081', 'abnormal circulating D-dimer level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893723, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0031107', 'abnormal circulating myoglobin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893724, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0003508', 'abnormal circulating dihydrotestosterone level', 0.44680851063829785, 12.982656403003482, 2.4084769817365386, 'UPHENO:0076290', 'abnormal androgen blood level'),
(893725, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0013255', 'abnormal circulating thrombin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893726, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893727, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0031075', 'abnormal circulating troponin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893728, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0012327', 'abnormal circulating factor VIII level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893729, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0012324', 'abnormal circulating antithrombin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893730, 'HP:0030347', 'Abnormal circulating androgen level', 'MP:0031067', 'abnormal blood oxygen saturation level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(893731, 'HP:0031281', 'Sialadenitis', 'MP:0000613', 'abnormal salivary gland morphology', 0.41509433962264153, 11.592196926445306, 2.193594157531978, 'UPHENO:0076751', 'abnormal saliva-secreting gland morphology'),
(893732, 'HP:0031281', 'Sialadenitis', 'MP:0000617', 'increased salivary gland mucosal cell number', 0.4074074074074074, 11.592196926445306, 2.1731881869638436, 'UPHENO:0076751', 'abnormal saliva-secreting gland morphology'),
(893733, 'HP:0031281', 'Sialadenitis', 'MP:0000452', 'abnormal mouth morphology', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(893734, 'HP:0031281', 'Sialadenitis', 'MP:0013818', 'abnormal oral cavity morphology', 0.4166666666666667, 9.27922043240247, 1.966301565588138, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(893735, 'HP:0034772', 'Decreased skull base length', 'MP:0030306', 'abnormal cranial fossa morphology', 0.4117647058823529, 9.312526519019649, 1.95820574586169, 'UPHENO:0086750', 'abnormal basicranium morphology'),
(893736, 'HP:0034772', 'Decreased skull base length', 'MP:0005352', 'small cranium', 0.4074074074074074, 7.821422361825214, 1.7850785435575467, 'UPHENO:0087814', 'abnormal cranium morphology'),
(893737, 'HP:0034772', 'Decreased skull base length', 'MP:0010031', 'abnormal cranium size', 0.44, 7.821422361825214, 1.8551080397656343, 'UPHENO:0087814', 'abnormal cranium morphology'),
(893738, 'HP:0034772', 'Decreased skull base length', 'MP:0008818', 'abnormal interfrontal bone morphology', 0.40350877192982454, 8.373527591151573, 1.838149024161554, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893739, 'HP:0034772', 'Decreased skull base length', 'MP:0000074', 'abnormal neurocranium morphology', 0.4166666666666667, 8.373527591151573, 1.8678784301036535, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893740, 'HP:0034772', 'Decreased skull base length', 'MP:0004421', 'enlarged parietal bone', 0.40350877192982454, 8.373527591151573, 1.838149024161554, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893741, 'HP:0034772', 'Decreased skull base length', 'MP:0030315', 'small neurocranium', 0.4339622641509434, 8.373527591151573, 1.9062515553794395, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893742, 'HP:0034772', 'Decreased skull base length', 'MP:0004422', 'small temporal bone', 0.41818181818181815, 8.373527591151573, 1.8712714909022115, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893743, 'HP:0034772', 'Decreased skull base length', 'MP:0030267', 'decreased basicranium angle', 0.4117647058823529, 9.312526519019649, 1.95820574586169, 'UPHENO:0086750', 'abnormal basicranium morphology'),
(893744, 'HP:0034772', 'Decreased skull base length', 'MP:0000919', 'cranioschisis', 0.43137254901960786, 7.821422361825214, 1.8368306675302175, 'UPHENO:0087814', 'abnormal cranium morphology'),
(893745, 'HP:0034772', 'Decreased skull base length', 'MP:0004386', 'enlarged interparietal bone', 0.4107142857142857, 8.373527591151573, 1.8544884479307715, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893746, 'HP:0034772', 'Decreased skull base length', 'MP:0004445', 'small exoccipital bone', 0.40350877192982454, 8.373527591151573, 1.838149024161554, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893747, 'HP:0034772', 'Decreased skull base length', 'MP:0004444', 'small supraoccipital bone', 0.40350877192982454, 8.373527591151573, 1.838149024161554, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893748, 'HP:0034772', 'Decreased skull base length', 'MP:0030077', 'small cranial cavity', 0.4074074074074074, 7.821422361825214, 1.7850785435575467, 'UPHENO:0087814', 'abnormal cranium morphology'),
(893749, 'HP:0034772', 'Decreased skull base length', 'MP:0030316', 'enlarged neurocranium', 0.4339622641509434, 8.373527591151573, 1.9062515553794395, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893750, 'HP:0034772', 'Decreased skull base length', 'MP:0000438', 'abnormal cranium morphology', 0.40425531914893614, 7.821422361825214, 1.7781596084374085, 'UPHENO:0087814', 'abnormal cranium morphology'),
(893751, 'HP:0034772', 'Decreased skull base length', 'MP:0030287', 'enlarged occipital bone', 0.41818181818181815, 8.373527591151573, 1.8712714909022115, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893752, 'HP:0034772', 'Decreased skull base length', 'MP:0004447', 'small basioccipital bone', 0.41379310344827586, 9.312526519019649, 1.963022987448061, 'UPHENO:0086750', 'abnormal basicranium morphology'),
(893753, 'HP:0034772', 'Decreased skull base length', 'MP:0004418', 'small parietal bone', 0.40350877192982454, 8.373527591151573, 1.838149024161554, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893754, 'HP:0034772', 'Decreased skull base length', 'MP:0009782', 'abnormal basicranium angle', 0.42, 9.312526519019649, 1.9776908600659135, 'UPHENO:0086750', 'abnormal basicranium morphology'),
(893755, 'HP:0034772', 'Decreased skull base length', 'MP:0010029', 'abnormal basicranium morphology', 0.42857142857142855, 9.312526519019649, 1.9977694546332325, 'UPHENO:0086750', 'abnormal basicranium morphology'),
(893756, 'HP:0034772', 'Decreased skull base length', 'MP:0000439', 'enlarged cranium', 0.4074074074074074, 7.821422361825214, 1.7850785435575467, 'UPHENO:0087814', 'abnormal cranium morphology'),
(893757, 'HP:0034772', 'Decreased skull base length', 'MP:0004442', 'occipital bone foramen', 0.42592592592592593, 8.373527591151573, 1.8885185973475407, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893758, 'HP:0034772', 'Decreased skull base length', 'MP:0004441', 'small occipital bone', 0.41818181818181815, 8.373527591151573, 1.8712714909022115, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893759, 'HP:0034772', 'Decreased skull base length', 'MP:0004384', 'small interparietal bone', 0.4107142857142857, 8.373527591151573, 1.8544884479307715, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893760, 'HP:0034772', 'Decreased skull base length', 'MP:0030279', 'thin neurocranium', 0.42592592592592593, 8.373527591151573, 1.8885185973475407, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(893761, 'HP:0034772', 'Decreased skull base length', 'MP:0030420', 'short basicranium', 0.42105263157894735, 9.312526519019649, 1.9801676185318144, 'UPHENO:0086750', 'abnormal basicranium morphology'),
(893762, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0011963', 'abnormal total retina thickness', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893763, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0003099', 'retina detachment', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893764, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0006188', 'calcified retina', 0.4375, 9.356059413574362, 2.023184616746278, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893765, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0020038', 'retina macular degeneration', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893766, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0020442', 'serous retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893767, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0020441', 'rhegmatogenous retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893768, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0006186', 'retina fibrosis', 0.4426229508196721, 9.356059413574362, 2.0349954854201657, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893769, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0009392', 'retina gliosis', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893770, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0001325', 'abnormal retina morphology', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893771, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0012671', 'retina spots', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893772, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0001329', 'retina hyperplasia', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893773, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0021107', 'retina fold', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893774, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0010707', 'decreased ventral retina size', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893775, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0020443', 'tractional retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893776, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0003455', 'decreased susceptibility to induced retina damage', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893777, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0001326', 'retina degeneration', 0.43548387096774194, 9.356059413574362, 2.01851751798877, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893778, 'HP:0031530', 'Multifocal subretinal deposits', 'MP:0006187', 'retina deposits', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(893779, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893780, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893781, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893782, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893783, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893784, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001846', 'increased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893785, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893786, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893787, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893788, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893789, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893790, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0010211', 'abnormal acute phase protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893791, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893792, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893793, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893794, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893795, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893796, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893797, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893798, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893799, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893800, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893801, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893802, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893803, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893804, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893805, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002472', 'impaired complement alternative pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893806, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893807, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893808, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893809, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893810, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893811, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893812, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008664', 'decreased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893813, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893814, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893815, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893816, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893817, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031053', 'pleuritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893818, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893819, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893820, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893821, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893822, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893823, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893824, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893825, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893826, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893827, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893828, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893829, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893830, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893831, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893832, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893833, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893834, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893835, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893836, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893837, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893838, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893839, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893840, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893841, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893842, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893843, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893844, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893845, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893846, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893847, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893848, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893849, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893850, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0013942', 'enthesitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893851, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031095', 'pharyngitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893852, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893853, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893854, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893855, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893856, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893857, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893858, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893859, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893860, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893861, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893862, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893863, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893864, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893865, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005001', 'abnormal clonal deletion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893866, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893867, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893868, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893869, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893870, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893871, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893872, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893873, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893874, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893875, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893876, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893877, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893878, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893879, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893880, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893881, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893882, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893883, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893884, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893885, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893886, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893887, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893888, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893889, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893890, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893891, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893892, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893893, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893894, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893895, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893896, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893897, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893898, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893899, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893900, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893901, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893902, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893903, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893904, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893905, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893906, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893907, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893908, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893909, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893910, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893911, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893912, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893913, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893914, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893915, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893916, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893917, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893918, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893919, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893920, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893921, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893922, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893923, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893924, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893925, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893926, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893927, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893928, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893929, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005005', 'abnormal self tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893930, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893931, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893932, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001790', 'abnormal immune system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893933, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893934, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893935, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893936, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893937, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893938, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893939, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893940, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893941, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893942, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893943, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893944, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008700', 'decreased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893945, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893946, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893947, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893948, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893949, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893950, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893951, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893952, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893953, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893954, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893955, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893956, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893957, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893958, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893959, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893960, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893961, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893962, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893963, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008661', 'decreased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893964, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893965, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893966, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893967, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893968, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893969, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893970, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893971, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893972, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893973, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893974, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893975, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893976, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893977, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893978, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893979, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893980, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893981, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893982, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893983, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893984, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003726', 'decreased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893985, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893986, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893987, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893988, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893989, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893990, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893991, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893992, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(893993, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893994, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893995, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003777', 'lip inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893996, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002409', 'decreased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893997, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893998, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(893999, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894000, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894001, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031222', 'decreased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894002, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894003, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894004, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894005, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008748', 'abnormal central T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894006, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894007, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894008, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894009, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894010, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894011, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894012, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894013, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894014, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894015, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894016, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894017, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894018, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894019, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894020, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894021, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008747', 'abnormal T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894022, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894023, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894024, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894025, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894026, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894027, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894028, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894029, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894030, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894031, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894032, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894033, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894034, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894035, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894036, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894037, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894038, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894039, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894040, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008693', 'increased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894041, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894042, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894043, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002499', 'chronic inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894044, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894045, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894046, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894047, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894048, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894049, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894050, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894051, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894052, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894053, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894054, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894055, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894056, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894057, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894058, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894059, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894060, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894061, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894062, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894063, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031066', 'cytokine storm', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894064, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894065, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894066, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894067, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894068, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894069, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894070, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894071, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894072, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894073, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008696', 'increased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894074, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894075, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894076, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894077, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894078, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894079, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894080, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894081, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894082, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894083, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894084, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894085, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894086, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894087, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894088, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894089, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894090, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004947', 'skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894091, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894092, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894093, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894094, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894095, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894096, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894097, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894098, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894099, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894100, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894101, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894102, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894103, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894104, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894105, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894106, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894107, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894108, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894109, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894110, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894111, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894112, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894113, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894114, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894115, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894116, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894117, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894118, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894119, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894120, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894121, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894122, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894123, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894124, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894125, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894126, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894127, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894128, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894129, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894130, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894131, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894132, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894133, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894134, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894135, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894136, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894137, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894138, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894139, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894140, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894141, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894142, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894143, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894144, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894145, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894146, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894147, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894148, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894149, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894150, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894151, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894152, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008744', 'abnormal B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894153, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894154, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894155, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894156, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894157, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894158, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894159, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894160, 'HP:0025351', 'Recurrent interdigital mycosis', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894161, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894162, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894163, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894164, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894165, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894166, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894167, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894168, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894169, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894170, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894171, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894172, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894173, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894174, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894175, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894176, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894177, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894178, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894179, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894180, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894181, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894182, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894183, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894184, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894185, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894186, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894187, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894188, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894189, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894190, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894191, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894192, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894193, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894194, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894195, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894196, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894197, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894198, 'HP:0033471', '10-minute APGAR score of 3', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(894199, 'HP:0003124', 'Hypercholesterolemia', 'MP:0003373', 'increased circulating mineralocorticoid level', 0.44285714285714284, 11.450642782231284, 2.251887862753541, 'UPHENO:0068047', 'increased level of lipid in blood'),
(894200, 'HP:0003124', 'Hypercholesterolemia', 'MP:0005186', 'increased circulating progesterone level', 0.43243243243243246, 11.450642782231284, 2.2252256764730967, 'UPHENO:0068047', 'increased level of lipid in blood'),
(894201, 'HP:0003124', 'Hypercholesterolemia', 'MP:0005178', 'increased circulating cholesterol level', 0.6212121212121212, 15.192109768632433, 3.0720551321647114, 'UPHENO:0068145', 'increased level of cholesterol in blood'),
(894202, 'HP:0003124', 'Hypercholesterolemia', 'MP:0005145', 'increased circulating VLDL cholesterol level', 0.4659090909090909, 15.192109768632433, 2.660477786281001, 'UPHENO:0068145', 'increased level of cholesterol in blood'),
(894203, 'HP:0003124', 'Hypercholesterolemia', 'MP:0003509', 'increased circulating dihydrotestosterone level', 0.4155844155844156, 11.450642782231284, 2.1814464670762597, 'UPHENO:0068047', 'increased level of lipid in blood'),
(894204, 'HP:0003124', 'Hypercholesterolemia', 'MP:0013405', 'increased circulating lactate level', 0.4126984126984127, 9.404207209241, 1.970051113027459, 'UPHENO:0079534', 'increased blood role level'),
(894205, 'HP:0003124', 'Hypercholesterolemia', 'MP:0002781', 'increased circulating testosterone level', 0.4050632911392405, 11.450642782231284, 2.1536562053936077, 'UPHENO:0068047', 'increased level of lipid in blood'),
(894206, 'HP:0003124', 'Hypercholesterolemia', 'MP:0003367', 'increased circulating glucocorticoid level', 0.44285714285714284, 11.450642782231284, 2.251887862753541, 'UPHENO:0068047', 'increased level of lipid in blood'),
(894207, 'HP:0003124', 'Hypercholesterolemia', 'MP:0000182', 'increased circulating LDL cholesterol level', 0.4659090909090909, 15.192109768632433, 2.660477786281001, 'UPHENO:0068145', 'increased level of cholesterol in blood'),
(894208, 'HP:0003124', 'Hypercholesterolemia', 'MP:0003443', 'increased circulating glycerol level', 0.4142857142857143, 9.93472192593978, 2.028746748442966, 'UPHENO:0051628', 'abnormal blood lipid level'),
(894209, 'HP:0003124', 'Hypercholesterolemia', 'MP:0005182', 'increased circulating estradiol level', 0.4383561643835616, 11.450642782231284, 2.2404151065695883, 'UPHENO:0068047', 'increased level of lipid in blood'),
(894210, 'HP:0003124', 'Hypercholesterolemia', 'MP:0001556', 'increased circulating HDL cholesterol level', 0.47126436781609193, 15.192109768632433, 2.6757242021380376, 'UPHENO:0068145', 'increased level of cholesterol in blood'),
(894211, 'HP:0001998', 'Neonatal hypoglycemia', 'MP:0013277', 'abnormal fasting circulating glucose level', 0.42857142857142855, 13.192109768632433, 2.3777639347533848, 'UPHENO:0051766', 'abnormal blood glucose level'),
(894212, 'HP:0001998', 'Neonatal hypoglycemia', 'MP:0000188', 'abnormal circulating glucose level', 0.4375, 13.192109768632433, 2.4024046336486884, 'UPHENO:0051766', 'abnormal blood glucose level'),
(894213, 'HP:0031468', 'Separation insecurity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894214, 'HP:0031468', 'Separation insecurity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894215, 'HP:0031468', 'Separation insecurity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894216, 'HP:0031468', 'Separation insecurity', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894217, 'HP:0031468', 'Separation insecurity', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894218, 'HP:0031468', 'Separation insecurity', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894219, 'HP:0031468', 'Separation insecurity', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894220, 'HP:0031468', 'Separation insecurity', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894221, 'HP:0031468', 'Separation insecurity', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894222, 'HP:0031468', 'Separation insecurity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894223, 'HP:0031468', 'Separation insecurity', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894224, 'HP:0031468', 'Separation insecurity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894225, 'HP:0031468', 'Separation insecurity', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894226, 'HP:0031468', 'Separation insecurity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894227, 'HP:0031468', 'Separation insecurity', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894228, 'HP:0031468', 'Separation insecurity', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894229, 'HP:0031468', 'Separation insecurity', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894230, 'HP:0031468', 'Separation insecurity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894231, 'HP:0031468', 'Separation insecurity', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894232, 'HP:0031468', 'Separation insecurity', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894233, 'HP:0031468', 'Separation insecurity', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894234, 'HP:0031468', 'Separation insecurity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894235, 'HP:0031468', 'Separation insecurity', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894236, 'HP:0031468', 'Separation insecurity', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894237, 'HP:0031468', 'Separation insecurity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894238, 'HP:0031468', 'Separation insecurity', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894239, 'HP:0031468', 'Separation insecurity', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894240, 'HP:0031468', 'Separation insecurity', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894241, 'HP:0031468', 'Separation insecurity', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894242, 'HP:0031468', 'Separation insecurity', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894243, 'HP:0031468', 'Separation insecurity', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894244, 'HP:0031468', 'Separation insecurity', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894245, 'HP:0031468', 'Separation insecurity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894246, 'HP:0031468', 'Separation insecurity', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894247, 'HP:0031468', 'Separation insecurity', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894248, 'HP:0031468', 'Separation insecurity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894249, 'HP:0031468', 'Separation insecurity', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894250, 'HP:0031468', 'Separation insecurity', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894251, 'HP:0031468', 'Separation insecurity', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894252, 'HP:0031468', 'Separation insecurity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894253, 'HP:0031468', 'Separation insecurity', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894254, 'HP:0031468', 'Separation insecurity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894255, 'HP:0031468', 'Separation insecurity', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894256, 'HP:0031468', 'Separation insecurity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894257, 'HP:0031468', 'Separation insecurity', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894258, 'HP:0031468', 'Separation insecurity', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894259, 'HP:0031468', 'Separation insecurity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894260, 'HP:0031468', 'Separation insecurity', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894261, 'HP:0031468', 'Separation insecurity', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894262, 'HP:0031468', 'Separation insecurity', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894263, 'HP:0031468', 'Separation insecurity', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894264, 'HP:0031468', 'Separation insecurity', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894265, 'HP:0031468', 'Separation insecurity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894266, 'HP:0031468', 'Separation insecurity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894267, 'HP:0031468', 'Separation insecurity', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894268, 'HP:0031468', 'Separation insecurity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894269, 'HP:0031468', 'Separation insecurity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894270, 'HP:0031468', 'Separation insecurity', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894271, 'HP:0031468', 'Separation insecurity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894272, 'HP:0031468', 'Separation insecurity', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894273, 'HP:0031468', 'Separation insecurity', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894274, 'HP:0031468', 'Separation insecurity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894275, 'HP:0031468', 'Separation insecurity', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894276, 'HP:0031468', 'Separation insecurity', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894277, 'HP:0031468', 'Separation insecurity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894278, 'HP:0031468', 'Separation insecurity', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894279, 'HP:0031468', 'Separation insecurity', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894280, 'HP:0031468', 'Separation insecurity', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894281, 'HP:0031468', 'Separation insecurity', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894282, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0013366', 'adrenal gland atrophy', 0.4444444444444444, 12.732678149995134, 2.3788585638209985, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(894283, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0000640', 'adrenal gland hypoplasia', 0.425531914893617, 12.732678149995134, 2.3276943345060466, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(894284, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0009078', 'adrenal gland hyperplasia', 0.4444444444444444, 12.732678149995134, 2.3788585638209985, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(894285, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0008289', 'abnormal adrenal medulla morphology', 0.41025641025641024, 11.397693902282326, 2.1624007458266665, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894286, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0002768', 'small adrenal glands', 0.47619047619047616, 12.732678149995134, 2.46235254815923, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(894287, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0020143', 'abnormal adrenal gland x-zone size', 0.4222222222222222, 11.397693902282326, 2.193709107340879, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894288, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0000642', 'enlarged adrenal glands', 0.47619047619047616, 12.732678149995134, 2.46235254815923, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(894289, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0000639', 'abnormal adrenal gland morphology', 0.43243243243243246, 11.397693902282326, 2.2200748857379224, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894290, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0008299', 'adrenal cortical hyperplasia', 0.41304347826086957, 11.397693902282326, 2.169733424536617, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894291, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0008291', 'abnormal adrenocortical cell morphology', 0.40425531914893614, 11.397693902282326, 2.146527052247193, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894292, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0008302', 'thin adrenal cortex', 0.40425531914893614, 11.397693902282326, 2.146527052247193, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894293, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0008300', 'enlarged adrenal medulla', 0.4318181818181818, 11.397693902282326, 2.218497567680373, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894294, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0008301', 'adrenal medulla hyperplasia', 0.40425531914893614, 11.397693902282326, 2.146527052247193, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894295, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0013565', 'abnormal adrenal gland capsule morphology', 0.41025641025641024, 11.397693902282326, 2.1624007458266665, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894296, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0013310', 'abnormal adrenal gland development', 0.41025641025641024, 11.397693902282326, 2.1624007458266665, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894297, 'HP:0006744', 'Adrenocortical carcinoma', 'MP:0012689', 'abnormal adrenal gland weight', 0.425, 11.397693902282326, 2.2009134259370557, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(894298, 'HP:0000712', 'Emotional lability', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894299, 'HP:0000712', 'Emotional lability', 'MP:0013806', 'encephalopathy', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894300, 'HP:0000712', 'Emotional lability', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894301, 'HP:0000712', 'Emotional lability', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894302, 'HP:0000712', 'Emotional lability', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894303, 'HP:0000712', 'Emotional lability', 'MP:0006080', 'brain ischemia', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894304, 'HP:0000712', 'Emotional lability', 'MP:0003880', 'abnormal central pattern generator function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894305, 'HP:0000712', 'Emotional lability', 'MP:0003633', 'abnormal nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894306, 'HP:0000712', 'Emotional lability', 'MP:0002634', 'abnormal sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894307, 'HP:0000712', 'Emotional lability', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(894308, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0001337', 'dry eyes', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894309, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0006190', 'retina ischemia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894310, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894311, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0003096', 'increased corneal light-scattering', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894312, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0002090', 'abnormal vision', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894313, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0020218', 'abnormal tear production', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894314, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0013145', 'eye discharge', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894315, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0005253', 'abnormal eye physiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894316, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0005551', 'abnormal eye electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894317, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0014132', 'abnormal tear film physiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894318, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0003011', 'delayed dark adaptation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894319, 'HP:0030569', 'Pinhole visual acuity 0.1 LogMAR', 'MP:0020860', 'abnormal cornea physiology', 0.4186046511627907, 8.795504987450572, 1.9188119493770963, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(894320, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0008816', 'petechiae', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894321, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894322, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001201', 'translucent skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894323, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001212', 'skin lesions', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894324, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001192', 'scaly skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894325, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0002060', 'abnormal skin morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894326, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894327, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894328, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894329, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009387', 'abnormal epidermal pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894330, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009379', 'abnormal foot pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894331, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009441', 'delayed skin barrier formation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894332, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001191', 'abnormal skin condition', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894333, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009603', 'absent keratohyalin granules', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894334, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0011239', 'abnormal skin coloration', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894335, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001216', 'abnormal epidermal layer morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894336, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001196', 'shiny skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894337, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0012078', 'abnormal tail ring morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894338, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0002095', 'abnormal skin pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894339, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894340, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0031103', 'skin rash', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894341, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009932', 'skin fibrosis', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894342, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009563', 'dyskeratosis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894343, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0003653', 'decreased skin turgor', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894344, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894345, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0004241', 'acantholysis', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894346, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0003941', 'abnormal skin development', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894347, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894348, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894349, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894350, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0003717', 'pallor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894351, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0002015', 'epithelioid cyst', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894352, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0003705', 'abnormal hypodermis morphology', 0.4074074074074074, 6.509554027552121, 1.6285086827350528, 'UPHENO:0002635', 'abnormal integument'),
(894353, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009827', 'skin detachment', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894354, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0003940', 'abnormal dermatome morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894355, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009605', 'decreased keratohyalin granule number', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894356, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009931', 'abnormal skin appearance', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894357, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0010232', 'delayed skin pigmentation appearance', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894358, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001209', 'spontaneous skin ulceration', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894359, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001203', 'increased sensitivity to skin irradiation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894360, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001211', 'wrinkled skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894361, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894362, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001198', 'tight skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894363, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001243', 'abnormal dermal layer morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894364, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009604', 'increased keratohyalin granule number', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894365, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009607', 'decreased keratohyalin granule size', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894366, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001210', 'skin ridges', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894367, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894368, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0002897', 'blotchy skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894369, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0005421', 'loose skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894370, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0011515', 'purpura', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894371, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0000367', 'abnormal coat/ hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(894372, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0010016', 'variable depigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894373, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0011160', 'dermal-epidermal separation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894374, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009385', 'abnormal dermal pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894375, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001202', 'skin photosensitivity', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894376, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001195', 'flaky skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894377, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0031309', 'skin cyst', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894378, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001208', 'blistering', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894379, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894380, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0013406', 'abnormal epidermal immune compartment', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894381, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001213', 'abnormal skin cell number', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894382, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0008854', 'bleb', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894383, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894384, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0008856', 'fetal bleb', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894385, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894386, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0003853', 'dry skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894387, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001230', 'epidermal desquamation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894388, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0005174', 'abnormal tail pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894389, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0010206', 'pigment incontinence', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894390, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894391, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0009606', 'increased keratohyalin granule size', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894392, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0003196', 'calcified skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894393, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0003652', 'abnormal skin turgor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894394, 'HP:0001008', 'Accumulation of melanosomes in melanocytes', 'MP:0001193', 'psoriasis', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(894395, 'HP:0001115', 'Posterior polar cataract', 'MP:0010260', 'posterior polar cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894396, 'HP:0001115', 'Posterior polar cataract', 'MP:0002697', 'abnormal eye size', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(894397, 'HP:0001115', 'Posterior polar cataract', 'MP:0010259', 'anterior polar cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894398, 'HP:0001115', 'Posterior polar cataract', 'MP:0010258', 'polar cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894399, 'HP:0001115', 'Posterior polar cataract', 'MP:0010257', 'posterior cortical cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894400, 'HP:0001115', 'Posterior polar cataract', 'MP:0013732', 'mature cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894401, 'HP:0001115', 'Posterior polar cataract', 'MP:0008841', 'ruptured lens capsule', 0.42857142857142855, 10.410750055107773, 2.1122854976583105, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(894402, 'HP:0001115', 'Posterior polar cataract', 'MP:0010262', 'lamellar cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894403, 'HP:0001115', 'Posterior polar cataract', 'MP:0010251', 'subcapsular cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894404, 'HP:0001115', 'Posterior polar cataract', 'MP:0010263', 'total cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894405, 'HP:0001115', 'Posterior polar cataract', 'MP:0010261', 'sutural cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894406, 'HP:0001115', 'Posterior polar cataract', 'MP:0010252', 'anterior subcapsular cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894407, 'HP:0001115', 'Posterior polar cataract', 'MP:0010255', 'cortical cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894408, 'HP:0001115', 'Posterior polar cataract', 'MP:0031345', 'developmental cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894409, 'HP:0001115', 'Posterior polar cataract', 'MP:0001306', 'small lens', 0.42857142857142855, 10.410750055107773, 2.1122854976583105, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(894410, 'HP:0001115', 'Posterior polar cataract', 'MP:0001304', 'cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894411, 'HP:0001115', 'Posterior polar cataract', 'MP:0010253', 'posterior subcapsular cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894412, 'HP:0001115', 'Posterior polar cataract', 'MP:0013731', 'immature cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894413, 'HP:0001115', 'Posterior polar cataract', 'MP:0010256', 'anterior cortical cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894414, 'HP:0001115', 'Posterior polar cataract', 'MP:0010254', 'nuclear cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(894415, 'HP:0001115', 'Posterior polar cataract', 'MP:0001305', 'enlarged lens', 0.42857142857142855, 10.410750055107773, 2.1122854976583105, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(894416, 'HP:0001115', 'Posterior polar cataract', 'MP:0003847', 'disorganized lens bow', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(894417, 'HP:0001115', 'Posterior polar cataract', 'MP:0031316', 'lentiglobus', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(894418, 'HP:0001115', 'Posterior polar cataract', 'MP:0001303', 'abnormal lens morphology', 0.4117647058823529, 10.410750055107773, 2.070453919906488, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(894419, 'HP:0001115', 'Posterior polar cataract', 'MP:0006225', 'ocular rupture', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(894420, 'HP:0001115', 'Posterior polar cataract', 'MP:0031317', 'spherophakia', 0.42105263157894735, 10.410750055107773, 2.093674689968286, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(894421, 'HP:0001115', 'Posterior polar cataract', 'MP:0006209', 'calcified intraocular region', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(894422, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0005416', 'abnormal circulating protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894423, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894424, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894425, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894426, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894427, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894428, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031081', 'abnormal circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894429, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0013256', 'increased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894430, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894431, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012616', 'increased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894432, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0030757', 'abnormal circulating histamine level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894433, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894434, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0013403', 'abnormal circulating lactate level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(894435, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894436, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894437, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894438, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012333', 'increased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894439, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894440, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011891', 'decreased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894441, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010091', 'decreased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894442, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0001560', 'abnormal circulating insulin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894443, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031082', 'decreased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894444, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012326', 'increased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894445, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0002965', 'increased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894446, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0005308', 'abnormal circulating ammonia level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894447, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894448, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011888', 'abnormal circulating total protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894449, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0008804', 'abnormal circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894450, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020248', 'decreased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894451, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894452, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020985', 'increased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894453, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031076', 'decreased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894454, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894455, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020246', 'abnormal circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894456, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012621', 'decreased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894457, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020256', 'abnormal circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894458, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012331', 'increased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894459, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894460, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0008805', 'decreased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894461, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031107', 'abnormal circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894462, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031077', 'increased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894463, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011894', 'decreased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894464, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020258', 'decreased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894465, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0005667', 'abnormal circulating leptin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894466, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894467, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031065', 'increased circulating procalcitonin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894468, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012618', 'decreased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894469, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0030745', 'increased circulating homocitrulline level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894470, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012324', 'abnormal circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894471, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894472, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894473, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894474, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012619', 'increased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894475, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010215', 'abnormal circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894476, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0008806', 'increased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894477, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0030624', 'abnormal circulating cysteine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894478, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020247', 'increased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894479, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894480, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012332', 'decreased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894481, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012666', 'increased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894482, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031059', 'increased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894483, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894484, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894485, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894486, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011890', 'increased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894487, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894488, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011912', 'abnormal circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894489, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012325', 'decreased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894490, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020257', 'increased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894491, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012222', 'decreased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894492, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012330', 'decreased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894493, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010210', 'abnormal circulating cytokine level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894494, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020255', 'absent circulating factor XII protein', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894495, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031079', 'increased circulating troponin I level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894496, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011886', 'increased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894497, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894498, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894499, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011893', 'increased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894500, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894501, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012614', 'abnormal circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894502, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0003349', 'abnormal circulating renin level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894503, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894504, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894505, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894506, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011889', 'abnormal circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894507, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0001570', 'abnormal circulating enzyme level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894508, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012327', 'abnormal circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894509, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031108', 'increased circulating myoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894510, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0005311', 'abnormal circulating amino acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894511, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894512, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0002695', 'abnormal circulating glucagon level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894513, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031083', 'increased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894514, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011892', 'abnormal circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894515, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0002941', 'increased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894516, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894517, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012615', 'decreased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894518, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012221', 'abnormal circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894519, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894520, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894521, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031075', 'abnormal circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894522, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010090', 'increased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894523, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0005567', 'decreased circulating total protein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894524, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012328', 'decreased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894525, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894526, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0008820', 'abnormal blood uric acid level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894527, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0013257', 'decreased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894528, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011887', 'decreased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894529, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894530, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012223', 'increased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894531, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894532, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894533, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894534, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894535, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894536, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020983', 'abnormal circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894537, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011885', 'abnormal circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894538, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894539, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894540, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894541, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894542, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0004730', 'abnormal circulating gastrin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894543, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0013255', 'abnormal circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894544, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894545, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0005419', 'decreased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894546, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012329', 'increased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894547, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894548, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0020984', 'decreased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894549, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012617', 'abnormal circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894550, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894551, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894552, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(894553, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894554, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031078', 'increased circulating troponin T level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894555, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012622', 'increased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894556, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894557, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894558, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894559, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894560, 'HP:0031032', 'Decreased retinol-binding protein level', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(894561, 'HP:0030260', 'Microphallus', 'MP:0003611', 'scrotum hypoplasia', 0.4426229508196721, 12.437222266468964, 2.3462736455035724, 'UPHENO:0087643', 'abnormal external male genitalia morphology'),
(894562, 'HP:0030260', 'Microphallus', 'MP:0009202', 'small external male genitalia', 0.45454545454545453, 14.491670050491338, 2.5665390607242538, 'UPHENO:0068843', 'decreased size of the external male genitalia'),
(894563, 'HP:0030260', 'Microphallus', 'MP:0003609', 'small scrotum', 0.4067796610169492, 12.437222266468964, 2.2492685605651226, 'UPHENO:0087643', 'abnormal external male genitalia morphology'),
(894564, 'HP:0030260', 'Microphallus', 'MP:0005188', 'small penis', 0.45, 15.607147267911275, 2.650135141942779, 'UPHENO:0069391', 'decreased size of the penis'),
(894565, 'HP:0030260', 'Microphallus', 'MP:0009201', 'external male genitalia atrophy', 0.43103448275862066, 14.491670050491338, 2.4992817977415287, 'UPHENO:0068843', 'decreased size of the external male genitalia'),
(894566, 'HP:0030260', 'Microphallus', 'MP:0009203', 'external male genitalia hypoplasia', 0.5178571428571429, 15.022184767190119, 2.7891478417267828, 'UPHENO:0081095', 'external male genitalia hypoplasia'),
(894567, 'HP:0030260', 'Microphallus', 'MP:0009207', 'internal male genitalia hypoplasia', 0.41379310344827586, 9.321745049049028, 1.96399435167202, 'UPHENO:0087802', 'abnormal male reproductive organ morphology'),
(894568, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894569, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894570, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894571, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894572, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894573, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894574, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894575, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894576, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894577, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894578, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894579, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894580, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894581, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894582, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894583, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894584, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894585, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894586, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894587, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894588, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894589, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894590, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894591, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894592, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894593, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894594, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894595, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894596, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894597, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894598, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894599, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894600, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894601, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894602, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894603, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894604, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894605, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894606, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894607, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894608, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894609, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894610, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894611, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894612, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894613, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894614, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894615, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894616, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894617, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894618, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894619, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894620, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894621, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894622, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894623, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894624, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894625, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894626, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894627, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894628, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894629, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894630, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894631, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894632, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894633, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894634, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894635, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894636, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894637, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894638, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894639, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894640, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894641, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894642, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894643, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894644, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894645, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894646, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894647, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894648, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894649, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894650, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894651, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894652, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894653, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894654, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894655, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894656, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894657, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894658, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894659, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894660, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894661, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894662, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894663, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894664, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894665, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894666, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894667, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894668, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894669, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894670, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894671, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894672, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894673, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894674, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894675, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894676, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894677, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894678, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894679, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894680, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894681, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894682, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894683, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894684, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894685, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894686, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894687, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894688, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894689, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894690, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894691, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894692, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894693, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894694, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894695, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894696, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894697, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894698, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894699, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894700, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894701, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894702, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894703, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894704, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894705, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894706, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894707, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894708, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894709, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894710, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894711, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894712, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894713, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894714, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894715, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894716, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894717, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894718, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894719, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894720, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894721, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894722, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894723, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894724, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894725, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894726, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894727, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894728, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894729, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894730, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894731, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894732, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894733, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894734, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894735, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894736, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894737, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894738, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894739, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894740, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894741, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894742, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894743, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894744, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894745, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894746, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894747, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894748, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894749, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894750, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894751, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894752, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894753, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894754, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894755, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894756, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894757, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894758, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894759, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894760, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894761, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894762, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894763, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894764, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894765, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894766, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894767, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894768, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894769, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894770, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894771, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894772, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894773, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894774, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894775, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894776, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894777, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894778, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894779, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894780, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894781, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894782, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894783, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894784, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894785, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894786, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894787, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894788, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894789, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894790, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894791, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894792, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894793, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894794, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894795, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894796, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894797, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894798, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894799, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894800, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894801, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894802, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894803, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894804, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894805, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894806, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894807, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894808, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894809, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894810, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894811, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894812, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894813, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894814, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894815, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894816, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894817, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894818, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894819, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894820, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894821, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894822, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894823, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894824, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894825, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894826, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894827, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894828, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894829, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894830, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894831, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894832, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894833, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894834, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894835, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894836, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894837, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894838, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894839, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894840, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894841, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894842, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894843, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894844, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894845, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894846, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894847, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894848, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894849, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894850, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894851, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894852, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894853, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894854, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894855, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894856, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894857, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894858, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894859, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894860, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894861, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894862, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894863, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894864, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894865, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894866, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894867, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894868, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894869, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894870, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894871, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894872, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894873, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894874, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894875, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894876, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894877, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894878, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894879, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894880, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894881, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894882, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894883, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894884, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894885, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894886, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894887, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894888, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894889, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894890, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894891, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894892, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894893, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894894, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894895, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894896, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894897, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894898, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894899, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894900, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894901, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894902, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894903, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894904, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894905, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894906, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894907, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894908, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894909, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894910, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894911, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894912, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894913, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894914, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894915, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894916, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894917, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894918, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894919, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894920, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894921, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894922, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894923, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894924, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894925, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894926, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894927, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894928, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894929, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894930, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894931, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894932, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894933, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894934, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894935, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894936, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894937, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894938, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894939, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894940, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894941, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894942, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894943, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894944, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894945, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894946, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894947, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894948, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894949, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894950, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894951, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894952, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894953, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894954, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894955, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894956, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894957, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894958, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894959, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894960, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894961, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894962, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894963, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894964, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894965, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894966, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894967, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894968, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894969, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894970, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894971, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894972, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894973, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894974, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894975, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894976, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894977, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894978, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894979, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894980, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894981, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894982, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894983, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894984, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894985, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894986, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894987, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894988, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894989, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894990, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894991, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894992, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894993, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894994, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894995, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894996, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(894997, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894998, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(894999, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895000, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895001, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895002, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895003, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895004, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895005, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895006, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895007, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895008, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895009, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895010, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895011, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895012, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895013, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895014, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895015, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895016, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895017, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895018, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895019, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895020, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895021, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895022, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895023, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895024, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895025, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895026, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895027, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895028, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895029, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895030, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895031, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895032, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895033, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895034, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895035, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895036, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895037, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895038, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895039, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895040, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895041, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895042, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895043, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895044, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895045, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895046, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895047, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895048, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895049, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895050, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895051, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895052, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895053, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895054, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895055, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895056, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895057, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895058, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895059, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895060, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895061, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895062, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895063, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895064, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895065, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895066, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895067, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895068, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895069, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895070, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895071, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895072, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895073, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895074, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895075, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895076, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895077, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895078, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895079, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895080, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895081, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895082, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895083, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895084, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895085, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895086, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895087, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895088, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895089, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895090, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895091, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895092, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895093, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895094, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895095, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895096, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895097, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895098, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895099, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895100, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895101, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895102, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895103, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895104, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895105, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895106, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895107, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895108, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895109, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895110, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895111, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895112, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895113, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895114, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895115, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895116, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895117, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895118, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895119, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895120, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895121, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895122, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895123, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895124, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895125, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895126, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895127, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895128, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895129, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895130, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895131, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895132, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895133, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895134, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895135, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895136, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895137, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895138, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895139, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895140, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895141, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895142, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895143, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895144, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895145, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895146, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895147, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895148, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895149, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895150, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895151, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895152, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895153, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895154, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895155, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895156, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895157, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895158, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895159, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895160, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895161, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895162, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895163, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895164, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895165, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895166, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895167, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895168, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895169, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895170, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895171, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895172, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895173, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895174, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895175, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895176, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895177, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895178, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895179, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895180, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895181, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895182, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895183, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895184, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895185, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895186, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895187, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895188, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895189, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895190, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895191, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895192, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895193, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895194, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895195, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895196, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895197, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895198, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895199, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895200, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895201, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895202, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895203, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895204, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895205, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895206, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895207, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895208, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895209, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895210, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895211, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895212, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895213, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895214, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895215, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895216, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895217, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895218, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895219, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895220, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895221, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895222, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895223, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895224, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895225, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895226, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895227, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895228, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895229, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895230, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895231, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895232, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895233, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895234, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895235, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895236, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895237, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895238, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895239, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895240, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895241, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895242, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895243, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895244, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895245, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895246, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895247, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895248, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895249, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895250, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895251, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895252, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895253, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895254, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895255, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895256, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895257, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895258, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895259, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895260, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895261, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895262, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895263, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895264, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895265, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895266, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895267, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895268, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895269, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895270, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895271, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895272, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895273, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895274, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895275, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895276, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895277, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895278, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895279, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895280, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895281, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895282, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895283, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895284, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895285, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895286, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895287, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895288, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895289, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895290, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895291, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895292, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895293, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895294, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895295, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895296, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895297, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895298, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895299, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895300, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895301, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895302, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895303, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895304, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895305, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895306, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895307, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895308, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895309, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895310, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895311, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895312, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895313, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895314, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895315, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(895316, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895317, 'HP:0031810', 'Anti-ganglioside antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(895318, 'HP:0007459', 'Generalized anhidrosis', 'MP:0005500', 'abnormal gustatory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895319, 'HP:0007459', 'Generalized anhidrosis', 'MP:0005421', 'loose skin', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895320, 'HP:0007459', 'Generalized anhidrosis', 'MP:0000685', 'abnormal immune system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895321, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013123', 'head/neck swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895322, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895323, 'HP:0007459', 'Generalized anhidrosis', 'MP:0031377', 'ambiguous external genitalia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895324, 'HP:0007459', 'Generalized anhidrosis', 'MP:0014134', 'abnormal embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895325, 'HP:0007459', 'Generalized anhidrosis', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895326, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002897', 'blotchy skin', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895327, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003385', 'abnormal body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895328, 'HP:0007459', 'Generalized anhidrosis', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895329, 'HP:0007459', 'Generalized anhidrosis', 'MP:0010478', 'intracranial aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895330, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001196', 'shiny skin', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895331, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001192', 'scaly skin', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895332, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003936', 'abnormal reproductive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895333, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002210', 'abnormal sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895334, 'HP:0007459', 'Generalized anhidrosis', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895335, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895336, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001195', 'flaky skin', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895337, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895338, 'HP:0007459', 'Generalized anhidrosis', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895339, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895340, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002132', 'abnormal respiratory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895341, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003115', 'abnormal respiratory system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895342, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003941', 'abnormal skin development', 0.43478260869565216, 6.509554027552121, 1.6823319772103247, 'UPHENO:0002635', 'abnormal integument'),
(895343, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895344, 'HP:0007459', 'Generalized anhidrosis', 'MP:0010352', 'gastrointestinal tract polyps', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895345, 'HP:0007459', 'Generalized anhidrosis', 'MP:0000752', 'dystrophic muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895346, 'HP:0007459', 'Generalized anhidrosis', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895347, 'HP:0007459', 'Generalized anhidrosis', 'MP:0008854', 'bleb', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895348, 'HP:0007459', 'Generalized anhidrosis', 'MP:0005499', 'abnormal olfactory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895349, 'HP:0007459', 'Generalized anhidrosis', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895350, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895351, 'HP:0007459', 'Generalized anhidrosis', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895352, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001243', 'abnormal dermal layer morphology', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895353, 'HP:0007459', 'Generalized anhidrosis', 'MP:0020982', 'abnormal skin adnexa development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895354, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002925', 'abnormal cardiovascular development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895355, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001193', 'psoriasis', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895356, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003853', 'dry skin', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895357, 'HP:0007459', 'Generalized anhidrosis', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895358, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013118', 'swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895359, 'HP:0007459', 'Generalized anhidrosis', 'MP:0011239', 'abnormal skin coloration', 0.43478260869565216, 6.509554027552121, 1.6823319772103247, 'UPHENO:0002635', 'abnormal integument'),
(895360, 'HP:0007459', 'Generalized anhidrosis', 'MP:0006281', 'abnormal tail development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895361, 'HP:0007459', 'Generalized anhidrosis', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895362, 'HP:0007459', 'Generalized anhidrosis', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895363, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001212', 'skin lesions', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895364, 'HP:0007459', 'Generalized anhidrosis', 'MP:0009931', 'abnormal skin appearance', 0.43478260869565216, 6.509554027552121, 1.6823319772103247, 'UPHENO:0002635', 'abnormal integument'),
(895365, 'HP:0007459', 'Generalized anhidrosis', 'MP:0004134', 'abnormal chest morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895366, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001726', 'abnormal allantois morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895367, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013124', 'mouth swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895368, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001983', 'abnormal olfactory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895369, 'HP:0007459', 'Generalized anhidrosis', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895370, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895371, 'HP:0007459', 'Generalized anhidrosis', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895372, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013177', 'abnormal tail tip morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895373, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003652', 'abnormal skin turgor', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895374, 'HP:0007459', 'Generalized anhidrosis', 'MP:0009827', 'skin detachment', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895375, 'HP:0007459', 'Generalized anhidrosis', 'MP:0010071', 'abnormal pruritus', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895376, 'HP:0007459', 'Generalized anhidrosis', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895377, 'HP:0007459', 'Generalized anhidrosis', 'MP:0009473', 'abnormal skin exfoliation', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895378, 'HP:0007459', 'Generalized anhidrosis', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895379, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003300', 'gastrointestinal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895380, 'HP:0007459', 'Generalized anhidrosis', 'MP:0031099', 'abnormal sputum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895381, 'HP:0007459', 'Generalized anhidrosis', 'MP:0009441', 'delayed skin barrier formation', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895382, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003861', 'abnormal nervous system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895383, 'HP:0007459', 'Generalized anhidrosis', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895384, 'HP:0007459', 'Generalized anhidrosis', 'MP:0005360', 'urolithiasis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895385, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001929', 'abnormal gametogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895386, 'HP:0007459', 'Generalized anhidrosis', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895387, 'HP:0007459', 'Generalized anhidrosis', 'MP:0031103', 'skin rash', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895388, 'HP:0007459', 'Generalized anhidrosis', 'MP:0009563', 'dyskeratosis', 0.43478260869565216, 6.509554027552121, 1.6823319772103247, 'UPHENO:0002635', 'abnormal integument'),
(895389, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003279', 'aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895390, 'HP:0007459', 'Generalized anhidrosis', 'MP:0030222', 'hyperostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895391, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001213', 'abnormal skin cell number', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895392, 'HP:0007459', 'Generalized anhidrosis', 'MP:0011174', 'lipodystrophy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895393, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001198', 'tight skin', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895394, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895395, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013119', 'abdomen swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895396, 'HP:0007459', 'Generalized anhidrosis', 'MP:0031277', 'pectus carinatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895397, 'HP:0007459', 'Generalized anhidrosis', 'MP:0020981', 'abnormal immune system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895398, 'HP:0007459', 'Generalized anhidrosis', 'MP:0005275', 'abnormal skin tensile strength', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895399, 'HP:0007459', 'Generalized anhidrosis', 'MP:0006279', 'abnormal limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895400, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003705', 'abnormal hypodermis morphology', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(895401, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002836', 'abnormal chorion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895402, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001216', 'abnormal epidermal layer morphology', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895403, 'HP:0007459', 'Generalized anhidrosis', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895404, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002163', 'abnormal gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895405, 'HP:0007459', 'Generalized anhidrosis', 'MP:0008856', 'fetal bleb', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895406, 'HP:0007459', 'Generalized anhidrosis', 'MP:0020973', 'abnormal gland development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895407, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002111', 'abnormal tail morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895408, 'HP:0007459', 'Generalized anhidrosis', 'MP:0002164', 'abnormal gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895409, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013283', 'failure of ventral body wall closure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895410, 'HP:0007459', 'Generalized anhidrosis', 'MP:0012514', 'pectus excavatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895411, 'HP:0007459', 'Generalized anhidrosis', 'MP:0010233', 'hairless tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895412, 'HP:0007459', 'Generalized anhidrosis', 'MP:0001210', 'skin ridges', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895413, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013332', 'peliosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895414, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013113', 'greasy tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895415, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003935', 'abnormal craniofacial development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895416, 'HP:0007459', 'Generalized anhidrosis', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895417, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013120', 'urogenital swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895418, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003795', 'abnormal bone structure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895419, 'HP:0007459', 'Generalized anhidrosis', 'MP:0003717', 'pallor', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895420, 'HP:0007459', 'Generalized anhidrosis', 'MP:0005029', 'abnormal amnion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895421, 'HP:0007459', 'Generalized anhidrosis', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(895422, 'HP:0007459', 'Generalized anhidrosis', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895423, 'HP:0007459', 'Generalized anhidrosis', 'MP:0000733', 'abnormal muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(895424, 'HP:0007459', 'Generalized anhidrosis', 'MP:0013121', 'testicular swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
